Search
forResearch 10 of 1000+
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Cutaneous toxicities of cancer therapy
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Skin toxicity of anti‐cancer therapy
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
Community 2 of 6
- Oral Biotin and Topical Minoxidil have a synergy effect in increasing hair growth, the study was only done in healthy subjects and it was only 14 days but it does prove that biotin can play a significant role as an adjunct treatment.
- The final nail in the coffin. PP405 is confirmed JXL069.
Learn
— no results
Try a deeper search in learn →